Breast cancer and hormone-replacement therapy in the Million Women Study

This publication has 18 references indexed in Scilit:

• Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women
  JAMA, 2003
• Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer
  JAMA, 2003
• Evidence from randomised trials on the long-term effects of hormone replacement therapy
  The Lancet, 2002
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin
  JNCI Journal of the National Cancer Institute, 2000
• Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
  JAMA, 2000
• The Million Women Study: design and characteristics of the study population
  Breast Cancer Research, 1999
• Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy
  International Journal of Cancer, 1999
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
  The Lancet, 1997
• The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
  New England Journal of Medicine, 1989